EmblemHealth prior authorization criteria
Documentation packets and P2P preparation by drug—for prescribers and PA staff. Verify the current member-specific payer criteria and timing before submission.
EmblemHealth reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. The applicable product, plan terms, request type, urgency, and governing law determine the decision and appeal clocks. Confirm both in the current member-specific source and denial notice. Criteria by drug appear below.
Prior authorization criteria by drug
Each page covers EmblemHealth's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at EmblemHealth →
- Aflibercept at EmblemHealth →
- Apixaban at EmblemHealth →
- Atezolizumab at EmblemHealth →
- Atogepant at EmblemHealth →
- Benralizumab at EmblemHealth →
- Bevacizumab at EmblemHealth →
- Bictegravir at EmblemHealth →
- Buprenorphine at EmblemHealth →
- Dapagliflozin at EmblemHealth →
- Dulaglutide at EmblemHealth →
- Dupilumab at EmblemHealth →
- Eculizumab at EmblemHealth →
- Elexacaftor Tezacaftor Ivacaftor at EmblemHealth →
- Empagliflozin at EmblemHealth →
- Erenumab at EmblemHealth →
- Evolocumab at EmblemHealth →
- Faricimab at EmblemHealth →
- Fingolimod at EmblemHealth →
- Fremanezumab at EmblemHealth →
- Galcanezumab at EmblemHealth →
- Glecaprevir Pibrentasvir at EmblemHealth →
- Guselkumab at EmblemHealth →
- Ibrutinib at EmblemHealth →
- Imatinib at EmblemHealth →
- Inclisiran at EmblemHealth →
- Infliximab at EmblemHealth →
- Ixekizumab at EmblemHealth →
- Lenalidomide at EmblemHealth →
- Liraglutide at EmblemHealth →
- Lisdexamfetamine at EmblemHealth →
- Mepolizumab at EmblemHealth →
- Methylphenidate at EmblemHealth →
- Naltrexone at EmblemHealth →
- Natalizumab at EmblemHealth →
- Nintedanib at EmblemHealth →
- Nivolumab at EmblemHealth →
- Nusinersen at EmblemHealth →
- Ocrelizumab at EmblemHealth →
- Ofatumumab at EmblemHealth →
- Omalizumab at EmblemHealth →
- Ozanimod at EmblemHealth →
- Palbociclib at EmblemHealth →
- Pembrolizumab at EmblemHealth →
- Pirfenidone at EmblemHealth →
- Ribociclib at EmblemHealth →
- Rimegepant at EmblemHealth →
- Risankizumab at EmblemHealth →
- Rituximab at EmblemHealth →
- Rivaroxaban at EmblemHealth →
- Sacubitril Valsartan at EmblemHealth →
- Secukinumab at EmblemHealth →
- Semaglutide at EmblemHealth →
- Sofosbuvir at EmblemHealth →
- Tafamidis at EmblemHealth →
- Tenofovir Alafenamide at EmblemHealth →
- Tezepelumab at EmblemHealth →
- Tirzepatide at EmblemHealth →
- Tofacitinib at EmblemHealth →
- Trastuzumab at EmblemHealth →
- Upadacitinib at EmblemHealth →
- Ustekinumab at EmblemHealth →
Generate a EmblemHealth PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to EmblemHealth's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com